-
System of a Down singer Serj Tankian covers fleeing the Lebanese Civil War as a child, advocating for recognition of the Armenian Genocide, and why his band hasn't made a new album since 2005.
-
When Thorsten Siess was in graduate school, he came up with the idea for a heart device that's now been used in hundreds of thousands of patients around the world.
-
Secretary of State Antony Blinken made an unannounced visit to Kyiv and said some new U.S. aid already arrived and more will reach the battlefield in the coming weeks.
-
The detonation marked a major step in freeing the Dali, which has been stuck among the wreckage since it crashed into one of the bridge's support columns shortly after leaving Baltimore on March 26.
-
The Carol Shields Prize for Fiction is a relatively new literary award given to women and nonbinary authors. This year's winner is V.V. Ganeshananthan for her book Brotherless Night.
-
At the European Hospital in Rafah, there are shortages of pain medication, antibiotics, even bandages, American volunteers say they are unable to save lives — and unable to evacuate to safety.
-
French Gates says she is "immensely proud" of the work of the Bill and Melinda Gates Foundation, and the decision to step down as co-chair was not easy. Her last day is June 7.
-
President Biden dramatically expanded two national monuments in California. But there are growing concerns that federal land managers are struggling to manage existing monuments designated since 2016.
-
Girl Scouts Troop 6,000 in New York City helps migrant girls establish connections and a platform to start a new life in a new country but also equips them with crucial life skills.
-
The bill faces a likely veto from Georgia's president, which parliament can override. Protesters who oppose the measure say it is modeled on a Russian law used to clamp down on dissent.
-
Shares in the video game retailer more than doubled at one point after a prominent meme stock investor made his first online posting in about three years.
-
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.